Key Record Dates
ClinicalTrials.gov Identifier: | NCT05281471 |
---|---|
Brief Title: | Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Platinum-doublet + Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (OnPrime, GOG-3076) |
First Submitted : | March 7, 2022 |
First Submitted that Met QC Criteria : | March 7, 2022 |
First Posted : | March 16, 2022 |
Last Update Submitted that Met QC Criteria : | April 5, 2023 |
Last Update Posted : | April 6, 2023 |